Page 82 - OR-1-1

Biol. 2020;21(10):571-584. doi: 10.1038/nature12517
doi: 10.1038/s41580-020-0259-3 52. Mellios N, Feldman DA, Sheridan SD, et al. MeCP2-
regulated miRNAs control early human neurogenesis
42. Lancaster MA, Corsini NS, Wolfinger S, et al. Guided self-
organization and cortical plate formation in human brain through differential effects on ERK and AKT signaling. Mol
Psychiatry. 2018;23(4):1051-1065.
organoids. Nat Biotechnol. 2017;35(7):659-666.
doi: 10.1038/mp.2017.86
doi: 10.1038/nbt.3906. Erratum in: Nat Biotechnol.
2018;36(10):1016. 53. Graham NSN, Jolly A, Zimmerman K, et al. Diffuse axonal
injury predicts neurodegeneration after moderate-severe
doi: 10.1038/nbt1018-1016a
traumatic brain injury. Brain. 2020;143(12):3685-3698.
43. Gonzales-Aloy E, Ahmed-Cox A, Tsoli M, Ziegler DS, doi: 10.1093/brain/awaa316
Kavallaris M. From cells to organoids: The evolution of
blood-brain barrier technology for modelling drug delivery 54. Palmieri M, Frati A, Santoro A, Frati P, Fineschi V, Pesce A.
in brain cancer. Adv Drug Deliv Rev. 2023;196:114777. Diffuse axonal injury: Clinical prognostic factors, molecular
experimental models and the impact of the trauma related
doi: 10.1016/j.addr.2023.114777
oxidative stress. An extensive review concerning milestones
44. Bergmann S, Lawler SE, Qu Y, et al. Blood-brain-barrier and advances. Int J Mol Sci. 2021;22(19):10865.
organoids for investigating the permeability of CNS doi: 10.3390/ijms221910865
therapeutics. Nat Protoc. 2018;13(12):2827-2843.
55. Graham NS, Sharp DJ. Understanding neurodegeneration
doi: 10.1038/s41596-018-0066-x after traumatic brain injury: From mechanisms to
45. Driehuis E, Kretzschmar K, Clevers H. Establishment clinical trials in dementia. J Neurol Neurosurg Psychiatry.
of patient-derived cancer organoids for drug-screening 2019;90(11):1221-1233.
applications. Nat Protoc. 2020;15(10):3380-3409. doi: 10.1136/jnnp-2017-317557
doi: 10.1038/s41596-020-0379-4. Erratum in: Nat Protoc. 56. Jha RM, Kochanek PM, Simard JM. Pathophysiology and
2021;16(12):5739. treatment of cerebral edema in traumatic brain injury.
doi: 10.1038/s41596-021-00494-5 Neuropharmacology. 2019;145(Pt B):230-246.
46. Xu C, Yuan X, Hou P, Li Z, Wang C, Fang C, Tan Y. doi: 10.1016/j.neuropharm.2018.08.004
Development of glioblastoma organoids and their 57. Ashina H, Porreca F, Anderson T, et al. Post-traumatic
applications in personalized therapy. Cancer Biol Med. headache: Epidemiology and pathophysiological insights.
2023;20(5):353-368. Nat Rev Neurol. 2019;15(10):607-617.
doi: 10.20892/j.issn.2095-3941.2023.0061 doi: 10.1038/s41582-019-0243-8
47. Rybin MJ, Ivan ME, Ayad NG, Zeier Z. Organoid models 58. Wang Q, Mergia E, Koesling D, Mittmann T. Nitric oxide/
of glioblastoma and their role in drug discovery. Front Cell cyclic guanosine monophosphate signaling via guanylyl
Neurosci. 2021;15:605255. cyclase isoform 1 mediates early changes in synaptic
doi: 10.3389/fncel.2021.605255 transmission and brain edema formation after traumatic
brain injury. J Neurotrauma. 2021;38(12):1689-1701.
48. Fan W, Christian KM, Song H, Ming GL. Applications
of brain organoids for infectious diseases. J Mol Biol. doi: 10.1089/neu.2020.7364
2022;434(3):167243. 59. Zhang C, Liu C, Li F, et al. Extracellular mitochondria
doi: 10.1016/j.jmb.2021.167243 activate microglia and contribute to neuroinflammation in
traumatic brain injury. Neurotox Res. 2022;40(6):2264-2277.
49. Gabriel E, Ramani A, Altinisik N, Gopalakrishnan J. Human
brain organoids to decode mechanisms of microcephaly. doi: 10.1007/s12640-022-00566-8
Front Cell Neurosci. 2020;14:115. 60. Robinson CP. Moderate and severe traumatic brain injury.
doi: 10.3389/fncel.2020.00115 Continuum (Minneap Minn). 2021;27(5):1278-1300.
50. Villanueva R. Advances in the knowledge and therapeutics doi: 10.1212/CON.0000000000001036
of schizophrenia, major depression disorder, and bipolar 61. Al-Dahhak R, Khoury R, Qazi E, Grossberg GT. Traumatic
disorder from human brain organoid research. Front brain injury, chronic traumatic encephalopathy, and
Psychiatry. 2023;14:1178494. Alzheimer disease. Clin Geriatr Med. 2018;34(4):617-635.
doi: 10.3389/fpsyt.2023.1178494 doi: 10.1016/j.cger.2018.06.008
51. Lancaster MA, Renner M, Martin CA, et al. Cerebral 62. Krishnamurthy K, Laskowitz DT. Cellular and molecular
organoids model human brain development and mechanisms of secondary neuronal injury following
microcephaly. Nature. 2013;501(7467):373-379. traumatic brain injury. In: Laskowitz D, Grant G, editors.

Volume 1 Issue 1 (2025) 16 doi: 10.36922/or.8261